“Molecular Docking Study of Nigella sativa Alkaloid Compounds as the Inhibitor of Papain-Like Protease SARS-CoV-2”, J. Trop. Pharm. Chem, vol. 7, no. 1, pp. 33–40, Feb. 2025, doi: 10.30872/j.trop.pharm.chem.v7i1.148.